|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
CELLTRION PHARM INC.
Main Activities: Pharmaceutical and Medicine Manufacturing
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name CELLTRION PHARM INC. Headquarters 17TH FL.,LG DAECOM BLDG.,706-1, YEOKSAM 2-DONG, GANGNAM-GU, SEOUL; Seoul; Seoul; 135918 |
Status: Listed Legal Form: Public Limited Company Operational Status: Operational Financial Auditors: LIAN (2011) Incorporation Date: November 17, 2000 Total Employees: 325 Tel: 02-2216-3611 |
|
Company Description |
| Firm's year-on-year sales went up, due to increase in clients thru continuous new service development. Firm's year-on-year profitability greatly deteriorated, in view of firm's operating profit turning into deficit, due to added burden stemming from surge of cost to purchase goods. Firm maintains very superior financial structure including realization of non-borrowings Mgt and ample liquidity. Firm signed a contract to supply bituminous coal worth KRW 76.49 billion with Hyundai Cement, which is | ||
|
||
Company Analysis |
| According to the Individual - Audited financial statement for the first half of 2012, total net operating revenues increased with 2.73%, from KRW 19,615,723 thousands to KRW 20,150,285 thousands. Operating result decreased from KRW 2,012,277 thousands to KRW 874,293 thousands which means -56.55% change. The results of the period increased 2.03% reaching KRW 1,434,514 thousands at the end of the period against KRW 1,405,905 thousands last year. Return on equity (Net income/Total equity) went from 1.12% to 1.09%, the Return On Asset (Net income / Total Asset) went from 0.80% to 0.58% and the Net Profit Margin (Net Income/Net Sales) went from 7.17% to 7.12% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 85.72% compared to 41.29% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 3.93 to 2.57 when compared to the previous year. |
Key Executives |
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
Companies with Similar Main Activities |
FULL COMPANY PROFILE
|
|
2012 Y (non-cons) |
2012 H1 (non-cons) |
|
 | ||
| Audited | Audited | |
| ||
| KR listed company financials | KR listed company financials | |
| ||
| Unit | Thousands | Thousands |
| ||
Balance Sheet
| ||
Total Assets |
330,075,784 |
245,542,795 |
| ||
Current Assets |
140,615,320 |
113,507,673 |
| ||
Total Liabilities |
173,859,494 |
113,330,657 |
| ||
Shareholders Equity |
156,216,290 |
132,212,137 |
| ||
Current Liabilities |
108,892,592 |
44,159,084 |
| ||
| * All the accounts are in KRW. | ||
Income Statement
| ||
Total Operating Revenue |
44,707,596 |
20,150,285 |
| ||
Operational Profit (Loss) |
5,083,772 |
874,293 |
| ||
Net Profit (Loss) |
3,936,477 |
1,434,514 |
| ||
| * All the accounts are in KRW. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Assets (ROA) |
1.19% |
0.58% |
| ||
Return on Equity (ROE) |
2.52% |
1.09% |
| ||
Return on Sales (ROS) |
8.8% |
7.12% |
| ||
Return on Capital |
1.78% |
0.71% |
| ||
Gross Profit Margin |
69.84% |
69.78% |
| Efficiency Ratios | ||
| ||
Current asset turnover |
0.32x |
0.18x |
| ||
Asset Turnover |
0.14x |
0.08x |
| Valuation figures and ratios | ||
| ||
Earning Before Interests and Taxes (EBIT) |
3,657,874 |
1,725,907 |
| ||
EBITDA |
5,221,410 |
939,448 |
| ||
Bookvalue (BV) |
118,834,901 |
99,941,923 |
| Liquidity Ratios | ||
| ||
Current Ratio |
129.13% |
257.04% |
| ||
Quick ratio |
51.65% |
146.72% |
| ||
Doom's day ratio |
2.75% |
2.75% |
| ||
Cash Flow to Debt |
0.93% |
-0.15% |
| Leverage Ratios | ||
| ||
Leverage ratio |
211.29% |
185.72% |
| ||
Interest Coverage Ratio |
475.12% |
277.55% |
| ||
Debt to equity |
111.29% |
85.72% |
| ||
Debt to total assets |
52.67% |
46.16% |
| ||
Long Term Debt to Capital |
29.37% |
34.35% |
| Market ratios | ||
| ||
Price/Book Ratio |
1.40 |
2.21 |
| Trend Ratios | ||
| ||
Revenue Trend |
105.76% |
102.73% |
| ||
Net Income Trend |
163.93% |
102.03% |
| ||
 |